These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15613314)

  • 1. Human immunodeficiency virus type 1 clade B superinfection: evidence for differential immune containment of distinct clade B strains.
    Yang OO; Daar ES; Jamieson BD; Balamurugan A; Smith DM; Pitt JA; Petropoulos CJ; Richman DD; Little SJ; Brown AJ
    J Virol; 2005 Jan; 79(2):860-8. PubMed ID: 15613314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus.
    Altfeld M; Allen TM; Yu XG; Johnston MN; Agrawal D; Korber BT; Montefiori DC; O'Connor DH; Davis BT; Lee PK; Maier EL; Harlow J; Goulder PJ; Brander C; Rosenberg ES; Walker BD
    Nature; 2002 Nov; 420(6914):434-9. PubMed ID: 12459786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The majority of currently circulating human immunodeficiency virus type 1 clade B viruses fail to prime cytotoxic T-lymphocyte responses against an otherwise immunodominant HLA-A2-restricted epitope: implications for vaccine design.
    Altfeld M; Allen TM; Kalife ET; Frahm N; Addo MM; Mothe BR; Rathod A; Reyor LL; Harlow J; Yu XG; Perkins B; Robinson LK; Sidney J; Alter G; Lichterfeld M; Sette A; Rosenberg ES; Goulder PJ; Brander C; Walker BD
    J Virol; 2005 Apr; 79(8):5000-5. PubMed ID: 15795285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of highly conserved and broadly cross-reactive HIV type 1 cytotoxic T lymphocyte epitopes as candidate immunogens for inclusion in Mycobacterium bovis BCG-vectored HIV vaccines.
    Ferrari G; Kostyu DD; Cox J; Dawson DV; Flores J; Weinhold KJ; Osmanov S
    AIDS Res Hum Retroviruses; 2000 Sep; 16(14):1433-43. PubMed ID: 11018863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Codon optimization of the tat antigen of human immunodeficiency virus type 1 generates strong immune responses in mice following genetic immunization.
    Ramakrishna L; Anand KK; Mohankumar KM; Ranga U
    J Virol; 2004 Sep; 78(17):9174-89. PubMed ID: 15308713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV type 1 superinfection with a dual-tropic virus and rapid progression to AIDS: a case report.
    Gottlieb GS; Nickle DC; Jensen MA; Wong KG; Kaslow RA; Shepherd JC; Margolick JB; Mullins JI
    Clin Infect Dis; 2007 Aug; 45(4):501-9. PubMed ID: 17638203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus type 1 specific cytotoxic T lymphocyte responses in Chinese infected with HIV-1 B'/C Recombinant (CRF07_BC).
    Chen J; Hong K; Jia M; Liu H; Zhang Y; Liu S; Zhang X; Zhao H; Peng H; Ma P; Xing H; Ruan Y; Williams KL; Yu XG; Altfeld M; Walker BD; Shao Y
    Retrovirology; 2007 Aug; 4():62. PubMed ID: 17727734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular immunity to human immunodeficiency virus type 1 (HIV-1) clades: relevance to HIV-1 vaccine trials in Uganda.
    Cao H; Mani I; Vincent R; Mugerwa R; Mugyenyi P; Kanki P; Ellner J; Walker BD
    J Infect Dis; 2000 Nov; 182(5):1350-6. PubMed ID: 11023458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of human immunodeficiency virus type 1 subtype C Gag-, Tat-, Rev-, and Nef-specific elispot-based cytotoxic T-lymphocyte responses for AIDS vaccine design.
    Novitsky V; Rybak N; McLane MF; Gilbert P; Chigwedere P; Klein I; Gaolekwe S; Chang SY; Peter T; Thior I; Ndung'u T; Vannberg F; Foley BT; Marlink R; Lee TH; Essex M
    J Virol; 2001 Oct; 75(19):9210-28. PubMed ID: 11533184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
    Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
    J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phylogenetic analysis of human immunodeficiency virus 1 in Ghana.
    Takehisa J; Osei-Kwasi M; Ayisi NK; Hishida O; Miura T; Igarashi T; Brandful J; Ampofo W; Netty VB; Mensah M; Yamashita M; Ido E; Hayami M
    Acta Virol; 1997 Feb; 41(1):51-4. PubMed ID: 9199716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T lymphocyte responses in HIV-1 infection: implications for vaccine development.
    Brander C; Walker BD
    Curr Opin Immunol; 1999 Aug; 11(4):451-9. PubMed ID: 10448136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of cross-clade CTL epitopes in HIV-1 clade A/E-infected individuals by using the clade B overlapping peptides.
    Watanabe K; Murakoshi H; Tamura Y; Koyanagi M; Chikata T; Gatanaga H; Oka S; Takiguchi M
    Microbes Infect; 2013 Nov; 15(13):874-86. PubMed ID: 23968885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of rhesus monkeys against infection with minimally pathogenic simian-human immunodeficiency virus: correlations with neutralizing antibodies and cytotoxic T cells.
    Quinnan GV; Yu XF; Lewis MG; Zhang PF; Sutter G; Silvera P; Dong M; Choudhary A; Sarkis PT; Bouma P; Zhang Z; Montefiori DC; Vancott TC; Broder CC
    J Virol; 2005 Mar; 79(6):3358-69. PubMed ID: 15731230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-clade envelope glycoprotein 160-specific CD8+ cytotoxic T lymphocyte responses in early HIV type 1 clade B infection.
    Wilson SE; Pedersen SL; Kunich JC; Wilkins VL; Mann DL; Mazzara GP; Tartaglia J; Celum CL; Sheppard HW
    AIDS Res Hum Retroviruses; 1998 Jul; 14(11):925-37. PubMed ID: 9686639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary human immunodeficiency virus type 1 (HIV-1) infection during HIV-1 Gag vaccination.
    Balamurugan A; Lewis MJ; Kitchen CM; Robertson MN; Shiver JW; Daar ES; Pitt J; Ali A; Ng HL; Currier JS; Yang OO
    J Virol; 2008 Mar; 82(6):2784-91. PubMed ID: 18199650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-subtype T-cell immune responses induced by a human immunodeficiency virus type 1 group m consensus env immunogen.
    Weaver EA; Lu Z; Camacho ZT; Moukdar F; Liao HX; Ma BJ; Muldoon M; Theiler J; Nabel GJ; Letvin NL; Korber BT; Hahn BH; Haynes BF; Gao F
    J Virol; 2006 Jul; 80(14):6745-56. PubMed ID: 16809280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous strain-specific cytolytic T lymphocyte responses directed against human immunodeficiency virus type 1 Env.
    Ray SC; Lubaki N; Dhruva BR; Siliciano RF; Bollinger RC
    AIDS Res Hum Retroviruses; 1998 Jan; 14(1):3-13. PubMed ID: 9453246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo compartmentalization of human immunodeficiency virus: evidence from the examination of pol sequences from autopsy tissues.
    Wong JK; Ignacio CC; Torriani F; Havlir D; Fitch NJ; Richman DD
    J Virol; 1997 Mar; 71(3):2059-71. PubMed ID: 9032338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.
    Koup RA; Safrit JT; Cao Y; Andrews CA; McLeod G; Borkowsky W; Farthing C; Ho DD
    J Virol; 1994 Jul; 68(7):4650-5. PubMed ID: 8207839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.